A pilot
A small, staged rollout with a handful of clinicians, agreed boundaries and an honest review at the end. We would rather hear what got in the way than what was impressive.
Work with us
Healing Space UK is being developed and evaluated, and the most useful thing an organisation can do right now is help work out where continuity of this kind genuinely helps. Practices and services fund access so their patients never pay β one per-clinician licence, agreed in writing.
All three start the same way: a conversation about your service, including where you think this would not work.
A small, staged rollout with a handful of clinicians, agreed boundaries and an honest review at the end. We would rather hear what got in the way than what was impressive.
Shaping the product around what your service actually needs, with preferential founding-partner terms. The shaping half is not a figure of speech.
Whether preserving therapeutic context helps is an open research question. If evaluating that properly is of interest β academically or as a funder β we would like to hear from you.
We will not publish a tier table no clinic has ever paid. What we will do is put a number in writing.
A single number, agreed for your service and fixed in the agreement. Patient access is always included β every patient, every feature, at no cost to them.
Early services shape the product and keep preferential terms as we grow. That trade is explicit and written down.
Monthly terms and no lock-in. Your service's data is exported for you on request if you decide to go.
A continuity layer around the work they already do β not a second records system to maintain.
Session Prep built around the interval since the last confirmed session: what the patient chose to share, the agenda they wrote, measure movement and agreed goals β with the original entry always reachable.
Goal changes are append-only and access to patient data is logged, so what was agreed and when it changed has an answer rather than a recollection.
The platform does not monitor for concerning patterns on your cliniciansβ behalf and makes no response-time promise. Safety monitoring and clinical judgement remain with your service.
Teams adopt safely when the rollout is honest about its pace.
Account setup, team roles, escalation boundaries, response expectations and governance contacts confirmed before any patient is invited.
A few patients start first, so clinicians can see what actually reaches them β and what does not, because a patient chose to keep it private. Then the workflow is tuned around how they already work.
What was genuinely useful, what got in the way, and what you would want changed. We would rather hear the second two.
Assurance claims are cheap. Here is where we honestly are β the same list a procurement process would ask for.
No NHS approval or assessment, no independent clinical validation, no regulatory approval, and no deployment at scale. We do not claim any of them, and we will say so the day that changes.
We have not shown that this improves therapeutic outcomes. We are speaking with practising therapists about where it is most useful β conversations, not endorsements, and nobody is named for credibility.
A DPIA and formal information-governance review are in preparation and not yet complete, and no independent penetration test or accessibility audit has been carried out. The Trust Centre lists the status of each.
The same intervention, described for the people who use it differently.
Tell us about your caseload and we will put a number in writing β or tell us why this would not work where you are, which is just as useful to us.